Markwayne Mullin’s financial dealings take on new importance as the Senate considers his nomination to lead an agency whose budget has vastly expanded.
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript March 17, 2026 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.27498 EPS, expectations were $-0.2.
Delivered record-high revenues, Adjusted EBITDA 1 , Adjusted EBITDA per shar e 1 since inception Generated record high cash flow from operations ...
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q4 2025 Earnings Call Transcript March 17, 2026 Academy Sports and Outdoors, Inc. misses on earnings expectations. Reported EPS is $1.97 EPS, ...
Good afternoon, and welcome to Petco's fourth quarter and fiscal 2025 earnings conference call. Joining me on the call today are Joel Anderson, Petco's Chief Executive Officer; and Sabrina Simmons, ...
In 2025, changes driven by the so-called Department of Government Efficiency cut IRS staffing by more than 25%.
After recently writing about Singularity in this column, I felt it was time to address the elephant in the room – the difference between Artificial Intelligence and Human Consciousness in the Age of ...
Nemesis gets a Summer 2026 release. Check streaming details, plot, teaser, and full character list in this complete fan guide ...
Susan Gilkerson, a math teacher and school bus driver, stood before a South Dakota education board and issued a warning. The proposed math standards the board was considering — just 36 pages, less ...
The New Republic on MSN
The Right-Wing French Sculptors Who Are Courting Elon Musk
Past a sloping grass bank on a deserted suburban street in the French commune of Meaux, a few miles from Paris, a blocked-off path leads to a row of corrugated sheds. A clip-art logo scrawled across a ...
Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsAnkit HiraJeffrey Thompson - Founder, President, CEO ...
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results